Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parathyroidectomy | 29 | 2014 | 45 | 5.420 |
Why?
|
| Parathyroid Hormone | 24 | 2012 | 117 | 3.100 |
Why?
|
| Hyperparathyroidism, Primary | 10 | 2014 | 14 | 2.380 |
Why?
|
| Hyperparathyroidism | 17 | 2012 | 40 | 2.380 |
Why?
|
| Thyroid Neoplasms | 5 | 2020 | 68 | 1.800 |
Why?
|
| Preoperative Care | 8 | 2015 | 275 | 1.170 |
Why?
|
| Thyroid Nodule | 3 | 2020 | 15 | 1.160 |
Why?
|
| Monitoring, Intraoperative | 12 | 2011 | 53 | 1.140 |
Why?
|
| Vocal Cord Paralysis | 2 | 2015 | 18 | 1.000 |
Why?
|
| Vocal Cords | 2 | 2015 | 18 | 1.000 |
Why?
|
| Laryngoscopy | 2 | 2015 | 61 | 0.980 |
Why?
|
| Calcium | 9 | 2012 | 929 | 0.730 |
Why?
|
| Parathyroid Neoplasms | 5 | 2021 | 13 | 0.610 |
Why?
|
| Hypothyroidism | 1 | 2017 | 24 | 0.590 |
Why?
|
| Thyrotropin | 1 | 2017 | 49 | 0.590 |
Why?
|
| Parathyroid Glands | 5 | 2013 | 22 | 0.550 |
Why?
|
| Postoperative Complications | 3 | 2017 | 1615 | 0.540 |
Why?
|
| Ultrasonography, Doppler | 2 | 2014 | 57 | 0.500 |
Why?
|
| Ultrasonography | 8 | 2020 | 453 | 0.490 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2013 | 14 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 201 | 0.410 |
Why?
|
| Sensitivity and Specificity | 11 | 2013 | 1753 | 0.360 |
Why?
|
| Humans | 38 | 2021 | 68618 | 0.350 |
Why?
|
| Thyroidectomy | 3 | 2014 | 31 | 0.350 |
Why?
|
| Jugular Veins | 1 | 2009 | 37 | 0.340 |
Why?
|
| Technetium Tc 99m Sestamibi | 8 | 2009 | 24 | 0.330 |
Why?
|
| Algorithms | 1 | 2014 | 1196 | 0.310 |
Why?
|
| Endocrine System Diseases | 1 | 2007 | 11 | 0.310 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 4848 | 0.300 |
Why?
|
| Immunoassay | 2 | 2005 | 64 | 0.290 |
Why?
|
| Retrospective Studies | 10 | 2017 | 7277 | 0.260 |
Why?
|
| Aged | 14 | 2017 | 14862 | 0.260 |
Why?
|
| Immunoradiometric Assay | 1 | 2004 | 3 | 0.250 |
Why?
|
| Adenoma | 2 | 2007 | 132 | 0.240 |
Why?
|
| Radiopharmaceuticals | 6 | 2009 | 114 | 0.240 |
Why?
|
| Insulinoma | 1 | 2002 | 4 | 0.220 |
Why?
|
| Adolescent | 8 | 2017 | 8912 | 0.220 |
Why?
|
| Middle Aged | 13 | 2017 | 21147 | 0.210 |
Why?
|
| Adult | 13 | 2017 | 21403 | 0.210 |
Why?
|
| Recurrence | 5 | 2008 | 948 | 0.200 |
Why?
|
| Feasibility Studies | 2 | 2014 | 652 | 0.190 |
Why?
|
| Intraoperative Period | 5 | 2004 | 62 | 0.190 |
Why?
|
| Treatment Outcome | 9 | 2011 | 7029 | 0.190 |
Why?
|
| Point-of-Care Systems | 1 | 2002 | 115 | 0.190 |
Why?
|
| Young Adult | 3 | 2017 | 5717 | 0.180 |
Why?
|
| Radionuclide Imaging | 7 | 2009 | 166 | 0.180 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 2077 | 0.170 |
Why?
|
| Hypercalcemia | 3 | 2012 | 34 | 0.170 |
Why?
|
| Insulin | 1 | 2002 | 619 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2002 | 332 | 0.170 |
Why?
|
| Predictive Value of Tests | 5 | 2007 | 1465 | 0.170 |
Why?
|
| Male | 15 | 2017 | 37321 | 0.160 |
Why?
|
| Female | 15 | 2017 | 38074 | 0.160 |
Why?
|
| Hormone Replacement Therapy | 1 | 2017 | 20 | 0.150 |
Why?
|
| Treatment Failure | 3 | 2007 | 216 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 772 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2007 | 3259 | 0.140 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2015 | 1 | 0.130 |
Why?
|
| Intraoperative Care | 2 | 2008 | 91 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 2 | 2014 | 504 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2014 | 163 | 0.110 |
Why?
|
| Surgeons | 1 | 2014 | 68 | 0.110 |
Why?
|
| Eligibility Determination | 1 | 2013 | 31 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2014 | 3705 | 0.110 |
Why?
|
| Thyroid Diseases | 1 | 2013 | 33 | 0.110 |
Why?
|
| Ambulatory Care | 2 | 2013 | 340 | 0.110 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 75 | 0.100 |
Why?
|
| Reference Values | 2 | 2012 | 579 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 504 | 0.090 |
Why?
|
| Postoperative Period | 3 | 2008 | 238 | 0.090 |
Why?
|
| Hyperplasia | 2 | 2007 | 89 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2014 | 2358 | 0.090 |
Why?
|
| Disease Management | 1 | 2012 | 248 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 85 | 0.080 |
Why?
|
| Reoperation | 2 | 2001 | 467 | 0.080 |
Why?
|
| Luminescent Measurements | 3 | 2005 | 58 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.070 |
Why?
|
| Time Factors | 2 | 2004 | 4655 | 0.060 |
Why?
|
| Incidence | 2 | 2007 | 1603 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 1851 | 0.060 |
Why?
|
| Hypoparathyroidism | 1 | 2002 | 4 | 0.050 |
Why?
|
| Pancreatic Diseases | 1 | 2002 | 66 | 0.050 |
Why?
|
| Hypoglycemia | 1 | 2002 | 72 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2002 | 631 | 0.040 |
Why?
|
| Remission Induction | 1 | 1999 | 111 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 403 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 446 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 438 | 0.040 |
Why?
|
| United States | 2 | 2021 | 7367 | 0.030 |
Why?
|
| Vocal Cord Dysfunction | 1 | 2013 | 1 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 52 | 0.030 |
Why?
|
| Hypocalcemia | 1 | 2013 | 13 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2013 | 18 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2013 | 129 | 0.030 |
Why?
|
| Consensus | 1 | 2013 | 211 | 0.030 |
Why?
|
| Neck | 2 | 2004 | 62 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2324 | 0.020 |
Why?
|
| Child | 1 | 2002 | 6405 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 383 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2005 | 63 | 0.020 |
Why?
|
| Physician's Role | 1 | 2005 | 116 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2004 | 76 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 508 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 274 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2004 | 258 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 2093 | 0.010 |
Why?
|
| Health Status | 1 | 1999 | 429 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 1054 | 0.010 |
Why?
|
| Disease Progression | 1 | 1999 | 1038 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 5731 | 0.010 |
Why?
|